SAHPRA-2022-0038-V238

Type IA variation for application SAHPRA-2022-0038. Type IA variation: New Dosage Strength for Crizotinabex — minor update

Variation Number
SAHPRA-2022-0038-V238
Type
Type IA
Application
SAHPRA-2022-0038
Change
CHG-2023-0238
Status
Active
Fee
€2,098
Submitted
2022-09-14
Approved
—
Description

Type IA variation: New Dosage Strength for Crizotinabex — minor update